Effect of Topical Naltrexone Ophthalmic Solution on the Signs and Symptoms of Dry Eye in Diabetic Subjects

Phase 2 Completed 60 enrolled Sassani, Joseph S., MD, MHA

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this exploratory study is to determine the safety and efficacy of 0.002% Naltrexone Ophthalmic Solution, compared to placebo for the treatment of the signs and symptoms of dry eye in diabetic subjects.

Timeline

Start: 2018-07-31
Primary completion: 2018-11-01
Completion: 2018-11-15

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Naltrexone	Small molecule	0.002 %	Topical

Effect of Topical Naltrexone Ophthalmic Solution on the Signs and Symptoms of Dry Eye in Diabetic Subjects

Summary

Timeline

Drugs

Indications